Paul Edwards Posted May 24, 2016 Share Posted May 24, 2016 The 2016 Annual Meeting of the American Society of Clinical Oncologists (ASCO) will be held in Chicago from 3 - 7 June. The New Prostate Cancer Infolink has a report on an abstract to be presented at ASCO about a phase II clinical trial of a new drug Ipataserib (GDC-0068) with Abiraterone in the treatment of metastatic castration-resistant prostate cancer. Click on this link to read the report. Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.